Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* COPD~* Current or exsmokers, 10 pack years~Exclusion Criteria:~* Asthma~* Any clinically relevant abnormal findings at screening examinations~* Recent COPD exacerbation

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): AZD3199 low dose
- 2 (Type: EXPERIMENTAL): AZD3199 intermediate dose
- 3 (Type: EXPERIMENTAL): AZD3199 high dose
- 4 (Type: ACTIVE_COMPARATOR): Formoterol 2x4.5 microgram bid
- 5 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).